Humacyte’s Bioengineered Tissue Platform Technology

Medtech Matters

Content provided by Medical Product Outsourcing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Product Outsourcing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2+ y ago 27:37

MP3•Episode home

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Juliana Blum, Co-founder and Executive Vice President of Corporate Development at Humacyte. She speaks to the technology behind their regenerative solution and how it can be leveraged as a technology platform to fulfill a variety of bioengineered tissue needs. Specifically, the following questions are addressed.

What is Humacyte and tell us a bit about your technology?
What are the applications for bioengineered tissue?
Obviously without giving away trade secrets, can you tell us a bit about how it is fabricated?
What were the major challenges that needed to be overcome to develop this?
What’s ahead for Humacyte?

Listen to this episode and see what you think of the company’s bioengineered tissue technology platform. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

For more medtech news and information, visit www.mpomag.com.

140 episodes

#Tech #Fitness #News #Tech News #Medical Product Outsourcing #Medtech #Medical Device #Oem #Contract Manufacturing